The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance-Reference-Cited by-同舟云学术

The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance

Published:2001-06 Issue:2 Volume:309 Page:437-445
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Hsiou Yu,Ding Jianping,Das Kalyan,Clark Arthur D,Boyer Paul L,Lewi Paul,Janssen Paul A.J,Kleim Jörg-Peter,Rösner Manfred,Hughes Stephen H,Arnold Edward

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference38 articles.

1. Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-Dihydroquinoxaline-2(1H)-Thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined presence of quinoxaline HBY 097 and 2′,3′-dideoxy-3′-thiacytidine (Lamivudine)

2. The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection;De Clercq;Antiviral Res.,1998

3. Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patients;Demeter;J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.,1998

4. Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents;Richman;Antimicrob. Agents Chemother.,1993

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of feline and human immunodeficiency virus reverse transcriptase enzymes through chemical screening and computational analysis;Chemical Biology & Drug Design;2024-05

2. Kinetic coevolutionary models predict the temporal emergence of HIV-1 resistance mutations under drug selection pressure;Proceedings of the National Academy of Sciences;2024-04

3. Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China;Journal of Antimicrobial Chemotherapy;2024-03-29

4. CHARACTERISATION AND STUDY OF 1- [2- (2-BENZOYLPHENOXY) ETHYL] -6-METHYLURACIL MECHANISM OF ACTION;Pharmacy & Pharmacology;2021-07-20

5. Structural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their Inhibition;Antiviral Drug Discovery and Development;2021